Callahan Advisors LLC Makes New $3.18 Million Investment in The Clorox Company $CLX

Callahan Advisors LLC bought a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 31,564 shares of the company’s stock, valued at approximately $3,183,000.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC lifted its holdings in Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock worth $3,173,000 after buying an additional 10,065 shares in the last quarter. Wilkins Investment Counsel Inc. lifted its holdings in Clorox by 250.6% during the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after buying an additional 39,360 shares in the last quarter. ProShare Advisors LLC lifted its holdings in Clorox by 11.7% during the 3rd quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after buying an additional 136,135 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Clorox by 27.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock valued at $114,506,000 after purchasing an additional 197,330 shares during the last quarter. Finally, Vest Financial LLC increased its position in shares of Clorox by 8.7% in the 3rd quarter. Vest Financial LLC now owns 417,229 shares of the company’s stock valued at $51,444,000 after purchasing an additional 33,267 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on CLX shares. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Finally, BNP Paribas Exane dropped their price objective on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $103.40.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox outperformed peers in a strong trading session, suggesting some investors were willing to buy the stock despite broader caution around the name. Clorox Co. stock outperforms competitors on strong trading day
• Neutral Sentiment: Wells Fargo reiterated its Hold rating on Clorox and also cut its price target to $95, signaling a cautious but not outright bearish stance. Wells Fargo Sticks to its Hold Rating for Clorox (CLX)
• Negative Sentiment: Wells Fargo’s price-target reduction adds to concerns that upside may be limited near term. Clorox (NYSE:CLX) Price Target Cut to $95.00 by Analysts at Wells Fargo & Company
• Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Clorox investors, which can raise overhang concerns even before any formal action is announced. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company – CLX
• Negative Sentiment: Zacks Research trimmed earnings estimates across multiple periods and kept a Strong Sell rating, reflecting expectations for softer profitability ahead.

Clorox Stock Up 1.7%

Shares of NYSE:CLX opened at $94.17 on Thursday. The stock has a market cap of $11.39 billion, a P/E ratio of 15.29, a P/E/G ratio of 0.48 and a beta of 0.59. The firm has a fifty day moving average price of $100.75 and a 200 day moving average price of $106.49. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $135.64.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were paid a dividend of $1.24 per share. The ex-dividend date was Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 5.3%. Clorox’s dividend payout ratio is currently 80.52%.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.